A gene library of Chiamydia trachomatis (serovar LI) DNA has been prepared in the phage vector X1059.
Members of the species Chlamydia trachomatis are obligate, intracellular, bacterial parasites of eucaryotic cells. They have long been known to be responsible for trachoma, the single largest cause of infectious human blindness, and more recently have been strongly implicated in genital tract infections which in frequency, severity, and syndrome range at least parallel gonococcal infections (23) .
A major immunogen of the host response to such infections is the chlamydial major outer membrane protein (MOMP) (17) . This surface-located (5, 20) polypeptide can induce antibody capable of neutralizing chlamydial infectivity in vitro (6) and contains epitopes which contribute to the species, sub-species, and type-specific (7) definition of the 15 currently known serovars of this species. For many other bacterial pathogens, such antigenic diversity of surface components provides a potentially important mechanism for evasion of the host immune response (3, 24, 25) .
The MOMP is also the most abundant polypeptide species of the infectious (elementary body [EB] ) and reproductive (reticulate body) forms of the organism (5, 13) . This substantial molar contribution of MOMP to the composition of the outer membranes of these parasites, which lack readily detectable quantities of muramic acid (1, 9, 16) , has led to the proposal that MOMP, in conjunction with other outer membrane components, contributes significantly to the structural integrity of the rigid form of these pathogens (5, 13, 18) .
Other possible biological functions of MOMP are at present unclear. On the basis of the general similarities between MOMP and outer membrane proteins of other gram-negative bacteria, it has been proposed (5) that MOMP may function as a porin, channeling nutrients toward the chlamydial cytosol. This raises the possibility that alterations in MOMP conformation, with concomitant changes in porin activity, * Corresponding author. may be involved in differentiation of the impermeable, metabolically inactive EB form to the permeable, metabolically active reticulate body form of the organism. Newhall and Jones (18) have reported the presence of disulfide-linked oligomeric complexes of MOMP in EB, and Hatch et al. (13) have described disulfide-linked homo-and hetero-oligomers of MOMP which are abundant in the EB but almost completely absent in the reticulate body. Hence, the possible conformational changes described above could involve reduction of disulfide bonds, leading to formation of a parasite membrane permeable to host nutrients. In favor of this proposal, Sarov and Becker (21) have reported that treatment of the EB with reducing agents led to enhanced incorporation of nucleotides into RNA.
It is clear that MOMP is a major and complex chlamydial antigen, that it may play an important structural role in the EB, and that it may possibly be involved in the regulation of the complex life cycle of these parasites. For these reasons the MOMP of C. trachomatis was chosen as the subject of this study.
Previously, progress in studies of the antigenic and biological properties of isolated chlamydial constituents has been severely hampered by the difficulty of producing large quantities of undenatured components from these fastidious pathogens. In an attempt to circumvent these problems, we prepared a library of chlamydial chromosomal In situ radioimmunoassay for detection of recombinant phage expressing products reactive with serum from a patient infected with C. trachomatis (L1). The in situ radioimmunoassay for detection of recombinant phage expressing products reactive with serum from a patient infected with C. trachomatis (L1) was performed as described by Wenman and Lovett (27) 13 ,500 x g, 25°C) and prepared for sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) by solubilization with SDS and ,B-mercaptoethanol. After resolution of polypeptides, SDS-PAGE gels (8 to 15% gradient) were processed for fluorography by using Fuji-RX film as described by Hames (11) .
Immunoprecipitation of radiolabeled, phage-encoded polypeptides. Phage-encoded polypeptides were radiolabeled in UV-irradiated E. coli as aureus cells (Cowan) was then added, and the suspension was incubated for 4 h at 0°C. Staphylococci were collected by centrifugation (Microfuge; 5 min, 13,500 x g, 25°C) and washed four times with 1 ml of 0.05% (vol/vol) Nonidet P-40 in TEN (10 mM Tris-hydrochloride [pH 8.0], 100 ml NaCl, 1 mM EDTA). Pelleted staphylococci were then prepared for SDS-PAGE by solubilization in 6.25 mM Tris-hydrochloride-2% (wt/vol) SDS-10% (vol/vol) glycerol-5% (vol/vol) 1B-mercaptoethanol for 10 min at 100°C.
SDS-PAGE and Western blotting. SDS-PAGE and Western blotting were performed as described by Hanffet al. (12) .
S. aureus-V8 protease peptide mapping. S. aureus-V8 protease peptide mapping was performed as described by Caldwell and Judd (4). Chlamydial MOMP was labeled with 1251 (4) after excision of the band from a preparative gel. Putative cloned MOMP was labeled with [3'S]methionine in irradiated E. coli as described above, and appropriate bands were excised from gels before peptide mapping.
RESULTS
Preparation of the C. trachomatis gene bank and selection of recombinant phage expressing seroreactive components. Purified L1 DNA was digested with Sau3A1 to create fragments of ca. 15 kilobases which were ligated to BamHI-cleaved vector phage X1059 DNA. Ligated DNA was then packaged in vitro and used to transfect E. coli Q359.
Plaques produced by ca. 1,000 such recombinant phage were screened for chlamydial antigen production by an in situ radioimmunoassay (27) with a high-titer human serum sample from a serovar L1 infection and 125I-labeled protein A from S. aureus. Twenty clones exhibiting various degrees of seroreactivity were selected for further characterization, and their polypeptide coding potential was examined by making use of the selective expression of phage DNA which occurs in uvrA mutants of E. coli K-12 after UV irradiation-induced suppression of endogenous protein synthesis (see below and above). On the basis of the apparent molecular weights (AMWs) of polypeptides expressed by the recombinant phage, one clone (designated D-2) was chosen for further study.
The seroreactivity of products expressed by clone D-2 is shown in Fig. 1 (Fig. lc) or NHS (Fig. ld) .
Selective expression of phage-encoded polypeptides in UV irradiated E. coli. Infection of UV-irradiated E. coli (M159; uvrA) bacterial cells led to the appearance of several polypeptides (Fig. 2, lane 3) which were not seen in parallel infections with vector phage (lane 2) or mock infections with no phage (lane 1). These polypeptides were tentatively assumed to be encoded by the chlamydial DNA insert. One of the components, a doublet (labeled with an arrowhead), migrated in SDS-PAGE with an AMW equivalent to that of the C. The 40-to 41-kd doublet specified by D-2 was precipitated by IHS but not NHS (Fig. 3) tides. Components of this AMW were not precipitated from polypeptides encoded by vector phage X1059 by reaction with either serum. Figure 4 shows the immunoreactivity of IHS and NHS with chlamydial polypeptides examined by Western blotting.
S. aureus-V8 protease peptide mapping of cloned and chlamydial products. The degree of relatedness between the chlamydial MOMP and the cloned product was further studied by peptide mapping of these components by using S. aureus-V8 protease, which specifically cleaves polypeptides on the carboxyl side of glutamic and, to a lesser extent, aspartic acid residues. Bands corresponding to the 40-to 41-kd doublet of D-2 and chlamydial MOMP were excised from gels and subjected to V8 protease hydrolysis, and the peptide fragments thus generated were resolved by SDS-PAGE. The peptide fragments generated from the upper and lower bands of the cloned doublet and the chlamydial MOMP were indistinguishable from each other (15.5, 13.8, and 11.5 kilobases; Fig. 5 ), indicating that there is a high degree of relatedness shared between the chlamydial and cloned products.
DISCUSSION
A gene bank of C. trachomatis (serovar LI) DNA was prepared in the phage vector X1059. Choice of this vector was influenced by (i) the ease with which phage plaques, in contrast to bacterial colonies, can be screened by an in situ radioimmunoassay (26) , (ii) the reported toxicity of outer membrane proteins for E. coli when present on plasmid vectors (10) , and (iii) the previously reported expression of a chlamydial antigen in this system (27) . From this library 20 clones exhibiting various degrees of seroreactivity with serum (IHS) from a patient with a C. trachomatis L1 infection were selected. Given the coding potential of the chlamydial genome (ca. 700 polypeptides of average size) and the reported existence of at least 20 chlamydial antigens (22) , this frequency of seroreactivity is compatible with the hypothesis that the majority of the chlamydial genome is readily expressed in E. coli. Examination of the polypeptides encoded by these recombinant phage showed several that code for more than one protein which could be immunoprecipitated by IHS (data not shown).
One clone, designated D-2, encoded polypeptides with AMWs of 40 and 41 kd which were not coded for by the vector phage and which could be immunoprecipitated by IHS but not NHS. These two polypeptides had indistinguishable S. aureus-V8 peptide maps (see below), suggesting that they may be different conformational forms of the same molecular species. Although the 40-kd species was the predominant form in polypeptide preparations before immunoprecipitation (Fig. 3, lane 2) , this procedure led to preferential precipitation of the 41-kd species (Fig. 3, lane 4) . This may have been due either to greater seroreactivity of the 41-kd form or conversion of the 40-kd form to the 41-kd form during the immunoprecipitation process.
Parallel experiments to immunoprecipitate chlamydial MOMP were not attempted, as release of this component from the EB requires exposure of the particles to denaturing 
